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To analyse the efficacy of Onabotulinumtoxin type A
(OnabotA) in chronic cluster headache patients.
Six patients (5 men and 1 woman) diagnosed with
refractory chronic cluster headache were included. Data
regarding the characteristics of the headache, the
frequency and the duration of the attacks, the presence of
family history of migraine and the analgesic use were
collected. The patients continued with their usual preven-
tative treatment.
In 4 of the 6 patients included (66.6%), we have observed
a clear improvement in the frequency of the headache
with a change in the pattern (from chronic to episodic).
All of these had family history of migraine. In one of the
patients no improvement was observed, and one patient
was lost during follow-up.
The use of OnabotA could be considered as a therapeu-
tic option in those patients with chronic cluster headache
which are intolerant or refractory to the known and used
preventative treatments, before using more invasive treat-
ments. Larger series are needed to confirm these findings.
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